[DOI] [PMC free article] [PubMed] [Google Scholar] 142.Unwin D, Unwin J, Crocombe D, et al
GLP-1s, especially for new users, can upset the gastrointestinal system, causing nausea, vomiting, constipation, diarrhea, and abdominal pain
So the FDA made an announcement: Its launching what it calls a green list of GLP-1 APIs from overseas facilities that the agency has inspected or evaluated that appear to be in compliance with the FDAs rigorous standards. GLP-1s coming from other sources will be subject to detention without physical examination. Some media outlets looking at you, Axios made it sound as if this green list was all about compounded drugs (and, to be fair, the FDA did throw a little unnecessary shade on compounding)
Complementary to pharmacokinetics is pharmacodynamics, which focuses on the effects of drugs in the body and their specific mechanisms of action at a molecular or cellular level
Insurance Coverage Realities Coverage for Diabetes As a rule, most health plans have at least one GLP-1 medication on their formulary for the treatment of diabetes